New York State Teachers Retirement System Invests $3.91 Million in Fortrea Holdings Inc. (NASDAQ:FTRE)

New York State Teachers Retirement System bought a new position in shares of Fortrea Holdings Inc. (NASDAQ:FTREFree Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 112,113 shares of the company’s stock, valued at approximately $3,913,000. New York State Teachers Retirement System owned 0.13% of Fortrea as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Whittier Trust Co. of Nevada Inc. purchased a new position in shares of Fortrea during the fourth quarter valued at $25,000. Whittier Trust Co. purchased a new position in shares of Fortrea during the fourth quarter valued at $25,000. ZRC Wealth Management LLC purchased a new position in shares of Fortrea during the fourth quarter valued at $27,000. Allworth Financial LP purchased a new position in shares of Fortrea during the fourth quarter valued at $28,000. Finally, Clean Yield Group purchased a new position in shares of Fortrea during the fourth quarter valued at $30,000.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on FTRE shares. Barclays lowered their price target on Fortrea from $38.00 to $35.00 and set an “overweight” rating on the stock in a report on Thursday, January 25th. Jefferies Financial Group started coverage on Fortrea in a report on Thursday, January 4th. They set a “buy” rating and a $44.00 price target on the stock. Deutsche Bank Aktiengesellschaft started coverage on Fortrea in a research note on Wednesday, March 6th. They issued a “hold” rating and a $36.00 target price on the stock. William Blair started coverage on Fortrea in a research note on Friday, January 5th. They issued a “market perform” rating on the stock. Finally, Robert W. Baird started coverage on Fortrea in a research note on Friday, March 22nd. They issued a “neutral” rating and a $43.00 target price on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $37.29.

Read Our Latest Analysis on FTRE

Fortrea Trading Down 0.6 %

FTRE opened at $39.05 on Monday. The stock has a 50-day moving average of $37.15 and a 200-day moving average of $33.10. Fortrea Holdings Inc. has a 52-week low of $24.92 and a 52-week high of $41.02. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.90.

Fortrea (NASDAQ:FTREGet Free Report) last released its quarterly earnings results on Monday, March 11th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.04). The firm had revenue of $775.40 million during the quarter, compared to the consensus estimate of $779.09 million. The firm’s quarterly revenue was up 1.8% on a year-over-year basis. Equities analysts forecast that Fortrea Holdings Inc. will post 1.06 earnings per share for the current fiscal year.

Fortrea Company Profile

(Free Report)

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.

Read More

Want to see what other hedge funds are holding FTRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fortrea Holdings Inc. (NASDAQ:FTREFree Report).

Institutional Ownership by Quarter for Fortrea (NASDAQ:FTRE)

Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.com's FREE daily email newsletter.